Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild-to-moderate essential hypertension

International Journal of Clinical Practice

Volumn 59, Issue 3, 2005, Pages 306-310

  Bilge, Ahmet Kaya ^a   Atilgan, D ^a   Tukek T ^a   Ozcan M ^a   Ozben B ^a   Koylan, N ^a   Meric M ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Amlodipine; Fosinopril; Heart rate variability; Left ventricular mass

Indexed keywords

AMLODIPINE; FOSINOPRIL;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MEASUREMENT; CALCULATION; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG DOSE REGIMEN; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE MASS; HEART RATE VARIABILITY; HUMAN; LONG TERM CARE; MALE; MONOTHERAPY; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; ELECTROCARDIOGRAPHY; FEMALE; FOSINOPRIL; HEART RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED;

EID: 14844350945     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2005.00464.x     Document Type: Article

References (22)

1. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93: 1043-65.
2. Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256-62.
3. Petretta M, Bonaduce D, Marciano F et al. Effects of 1 year of lisinopril treatment on cardiac autonomic control in hypertensive patients with left ventricular hypertrophy. Hypertension 1996; 27: 330-8.
4. Lombardo M, Alli C, Broccolino M et al. Long-term effects of angiotensin-converting enzyme inhibitors and calcium antagonists on the right and left ventricles in essential hypertension. Am Heart J 1997; 134: 557-64.
5. Sakata K, Shirotani M, Yoshida H, Kurata C. Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension. J Am Coll Cardiol 1998; 32: 438-43.
6. Vesalainen RK, Kantola IM, Airaksinen KE, Tahvanainen KU, Kaila TJ. Vagal cardiac activity in essential hypertension. the effects of metoprolol and ramipril. Am J Hypertens 1998; 11: 649-58.
7. Sakata K, Shirotani M, Yoshida H et al. Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neuro-hormonal status in essential hypertension. Hypertension 1999; 33: 1447-52.
8. Ylitalo A, Airaksinen KE, Sellin L, Huikuri HV. Effects of combination antihypertensive therapy on baroreflex sensitivity and heart rate variability in systemic hypertension. Am J Cardiol 1999; 83 885-9.
9. Wolk R, Somers VK. Autonomic effects of vasoactive drugs: physiological insights and clinical implications. J Hypertens 2002; 20: 1057-60.
10. Wolk R, Kulakowski P, Ceremuzynski L. Nifedipine and captopril exert divergent effects on heart rate variability in patients with acute episodes of hypertension. J Hum Hypertens 1996; 10 327-32.
11. Okabayashi J, Matsubayashi K, Doi Y, Sato T, Ozawa T. Effects of nifedipine and enalapril on cardiac autonomic nervous function during the tilt test in elderly patients with hypertension. Hypertens Res 1997; 20: 1-6.
12. Fuberg CD, Psaty BM. Calcium-antagonists: not appropriate as first-line antihypertensive agents. Am J Hypertens 1996; 9: 122-5.
13. Frans HH, Leenen F, Anne F. Comparison of the effects of amlodipine and diltiazem on 24-hour blood pressure, plasma catecholamines, and left ventricular mass. Am J Cardiol 1996; 78 203-7.
14. Declaration of Helsinki: Recommendation Guiding Physicians in Biomedical Research Involving Human Subjects. 41st World Medical Assembly, Hong-Kong, September 1989.
15. Sahn DJ, De Maria A, Kisslo J, Weiman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
16. Woythaler JN, Singer SL, Kwan OL et al. Accuracy of echocardiography versus electrocardiography in detecting left ventricular hypertrophy: comparison with postmortem mass measurements. J Am Coll Cardiol 1983; 2: 305-11.
17. Appel LJ, Whelton PK, Seider AJ, Patel AR, Klag MJ. The accuracy and precision of the Accutracker ambulatory blood pressure monitor. Am J Epidemiol 1990; 132: 343-54.
18. Stephenson RB, Smith OA, Scher AM. Baroreceptor regulation of heart rate in baboons during different behavioral states. Am J Physiol 1981; 241: 277-85.
19. Tomiyama H, Kimura Y, Sakuma Y et al. Effects of an ACE inhibitor and calcium channel blocker on cardiovascular autonomic nervous system and carotid distensibility in patients with mild to moderate hypertension. Am J Hypertens 1998; 11: 682-9.
20. Hohnloser SH, Klingenheben T, van de Loo A, Hablawetz E, Just H, Schwartz PJ. Reflex versus tonic vagal activity as a prognostic parameter in patients with sustained ventricular tachycardia or ventricular fibrillation. Circulation 1994; 89: 1068-73.
21. Schwartz PJ, LaRovere MT, Vanoli E. Autonomic nervous system and sudden death. Circulation 1992; 85 (Suppl. 1): 77-91.
22. Julius S, Pascual AV, London R. Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation 1971; 44: 413-8.